Arcadia Biosciences, Inc.·4

Apr 28, 5:26 PM ET

Jacot Stanley Jr 4

4 · Arcadia Biosciences, Inc. · Filed Apr 28, 2023

Insider Transaction Report

Form 4
Period: 2023-04-04
Jacot Stanley Jr
Chief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-04+1,5009,402 total
    Exercise: $7.55Exp: 2033-04-04Common Stock (1,500 underlying)
Footnotes (1)
  • [F1]The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT